Management and outcomes of side effects with focus on anaemia in patients with hepatitis C genotype 1 infection: the telaprevir early access program in patients from Romania
[摘要]
[发布日期] 2013-12-16 [发布机构]
[效力级别] [学科分类]
[关键词] Erythropoietin;Common Adverse Event;Iron Supplement;Significant Adverse Event;Telaprevir [时效性]
